Teva Canada Limited Product Recall (2020-08-21)
- Starting date:
- August 21, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-73827
Last updated:
2020-08-28
Summary
-
Product:
A. TEVA-CEPHALEXIN 125B. TEVA-CEPHALEXIN 250
A. TEVA-CEPHALEXIN 125
B. TEVA-CEPHALEXIN 250
Reason
The affected lots may not meet the specification for assay.
Depth of distribution
Wholesalers, Retailers
Affected products
TEVA-CEPHALEXIN 125
DIN, NPN, DIN-HIM
DIN 00342106
Dosage form
Powder for suspension
Strength
Cephalexin (Cephalexin Monohydrate) 125 MG/5ML
Lot or serial number
30309916A
30309917A
30310026A
30310027A
Companies
- Recalling Firm
-
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
TEVA-CEPHALEXIN 250
DIN, NPN, DIN-HIM
DIN 00342092
Dosage form
Powder for suspension
Strength
Cephalexin (Cephalexin Monohydrate) 250 MG/5ML
Lot or serial number
30309837A, 30309838A, 30309839A, 30309840A, 30309841A, 30309842A, 30309843A, 30309844A, 30309972A, 30309973A, 30309974A, 30309975A, 30309976A, 30309977A, 30309978A, 30310049A, 30310050A, 30310051A, 30310052A, 30310053A, 30310123A, 30310124A, 30310125A, 30310126A, 30310150A, 30310151A, 30310152A, 30310153A, 30310154A, 30310218A, 30310219A, 30310220A, 30310221A, 30310278A, 30310279A, 30310280A, 30310281A, 30310383A, 30310384A, 30310385A, 30310386A, 30310434A, 30310435A, 30310436A, 30310437A, 30310438A, 30310494A, 30310496A, 30310497A
Companies
- Recalling Firm
-
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA